Effects of Huanglian Jiedu Decoction on blood lipid metabolism and its related gene expressions in rats with hyperlipidemia

Journal of Chinese Integrative Medicine

Volumn 8, Issue 3, 2010, Pages 275-279

  Jin, Jin ^a   Zhang, Yang ^a   Hu, Wen Xiang ^b   Zhang, Zheng Yao ^a   Xu, Nan Nan ^b   Zhou, Qiu Li ^a  

^a JILIN UNIVERSITY   (China)

^b CAPITAL NORMAL UNIVERSITY   (China)

Author keywords

Compound (TCD); Hyperlipidemia; Low density lipoprotein receptor; Peroxisome proliferator activated receptor ; Rats

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHINESE DRUG; CHOLESTEROL; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUANGLIAN JIEDU; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HERBAL MEDICINE; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIPID DIET; LIPID METABOLISM; LOW DRUG DOSE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; DRUGS, CHINESE HERBAL; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LDL; TRIGLYCERIDES;

EID: 77949596227     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20100313     Document Type: Article

References (10)

1. Jin D, Lu FE, Chen G, Sun H, Lu XH. Effects of Huanglian Jiedu Decoction on phosphatidylinositol-3-kinase expression in target tissues of type 2 diabetic rats. J Chin Integr Med. 2007; 5(5):541-545. Chinese with abstract in English.
2. Leng SH, Lu FE, Tu QN, Xu LJ, Yang MW, Wang KF. Effects of Huanglian Jiedu Decoction on blood glucose and lipids metabolisms in type 2 diabetic rats. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi. 2003; 9(4):4388-4389. Chinese with abstract in English.
3. Ding LB, Lu FE, Ye AL, Xu LJ, Wang KF. Effects of Huanglian Jiedu Decoction on leptin and resistin in insulin resistive rats. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006; 26(3):232-235. Chinese with abstract in English.
4. Chira EC, McMillen TS, Wang S, Haw A 3rd, O'Brien KD, Wight TN, Chait A. Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice. Atherosclerosis. 2007; 195(1):100-109.
5. Chen KX. Comprehension on treatment based on typing of hyperlipidemia. Shi Zhen Guo Yi Guo Yao. 2002; 12(13):750-751. Chinese.
6. Zhang Y, Xie ML, Zhu LJ, Gu ZL. Therapeutic effect of osthole on hyperlipidemic fatty liver in rats. Acta Pharmacol Sin. 2007; 28(3):398-403.
7. Stulnig TM, Klocker H, Harwood HJ Jr, Jurgens G, Schönitzer D, Jarosch E, Huber LA, Amberger A, Wick G. In vivo LDL receptor and HMG-CoA reductase regulation in human lymphocytes and its alterations during aging. Arterioscler Thromb Vase Biol. 1995; 15(7):872-878.
8. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004; 10(12):1344-1351.
9. Hammarstedt A, Andersson CX, Rotter Sopasakis V, Smith U. The effect of PPARgamma ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot Essent Fatty Acids. 2005; 73(1):65-75.
10. Huang C, Zhang Y, Gong Z, Sheng X, Li Z, Zhang W, Qin Y. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem Biophys Res Commun. 2006; 348(2):571-578.